Summary: Exercise of governmental authority to control conduct.
Publications221 found, 100 shown here
- FDA regulation of stem-cell-based therapiesDina Gould Halme
School of Medicine, University of California at San Francisco, San Francisco, USA
N Engl J Med 355:1730-5. 2006
- Understanding Philip Morris's pursuit of US government regulation of tobaccoP A McDaniel
Center for Tobacco Control Research and Education, University of California, San Francisco, 530 Parnassus Avenue, Suite 366, San Francisco, CA 94143 1390, USA
Tob Control 14:193-200. 2005..To investigate Philip Morris's support of US Food and Drug Administration (FDA) regulation of tobacco products and analyse its relationship to the company's image enhancement strategies...
- Decline in hospitalisations due to dog bite injuries in Catalonia, 1997-2008. An effect of government regulation?Joan R Villalbí
Agència de Salut Pública de Barcelona, Barcelona, Spain
Inj Prev 16:408-10. 2010..To analyse population-based data on hospitalisation caused by dog bite injuries after changes in legal regulations on dog ownership, including breed-specific regulations...
- Scientific and legal perspectives on science generated for regulatory activitiesCarol J Henry
American Chemistry Council, Arlington, Virginia, USA
Environ Health Perspect 116:136-41. 2008..In a closely related example, the U.S. Environmental Protection Agency considered but abandoned a program to implement standards aimed at "external" information...
- Naturally occurring asbestos: a recurring public policy challengeR J Lee
RJ Lee Group Inc, Monroeville, PA 15146, USA
J Hazard Mater 153:1-21. 2008....
- Government regulation of sex and sexuality: in their own wordsSofia Gruskin
Department of Global Health and Population, Harvard School of Public Health, Boston, MA, USA
Reprod Health Matters 17:108-18. 2009....
- Ambient air pollution: health hazards to childrenJanice J Kim
Pediatrics 114:1699-707. 2004....
- Modern regulatory impact analysis: the experience of the European UnionBruce Ballantine
Business Decisions Limited, Heronswood House, Maidstone Road, Pembury, Kent TN2 4DD, UK
Regul Toxicol Pharmacol 44:57-68. 2006..The paper finally draws a number of conclusions and makes a number of recommendations for further improvements in the quality of the regulatory process in the European Union...
- Organophosphate exposures in the United States: a longitudinal analysis of incidents reported to poison centersDaniel L Sudakin
Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, Oregon 97331 6502, USA
J Toxicol Environ Health A 70:141-7. 2007..The results of this investigation are consistent with other studies that have reported that regulatory restriction of access to pesticide formulations may have a significant impact on the number of human exposure incidents...
- Regulatory parallels to Daubert: stakeholder influence, "sound science," and the delayed adoption of health-protective standardsRoni A Neff
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St, Room E6636, Baltimore, MD 21205, USA
Am J Public Health 95:S81-91. 2005..Most recently, political tampering with science provides the foundation for some policymakers to disregard science completely in the environmental regulatory process...
- Environmental pediatrics and its impact on government health policyLynn Goldman
Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 20815, USA
Pediatrics 113:1146-57. 2004..More recently, these issues have been taken up by states and in the international arena...
- Manufacturing uncertainty: contested science and the protection of the public's health and environmentDavid Michaels
Department of Environmental and Occupational Health, George Washington University School of Public Health and Health Services, 2100 M St NW, Suite 203, Washington, DC 20037, USA
Am J Public Health 95:S39-48. 2005..The public health system must ensure that scientific evidence is evaluated in a manner that assures the public's health and environment will be adequately protected...
- Learning the value of drugs--is rofecoxib a regulatory success story?Rebecca S Eisenberg
University of Michigan Law School, Ann Arbor, USA
N Engl J Med 352:1285-7. 2005
- Legislating "sound science": the role of the tobacco industryAnnamaria Baba
Department of Clinical Pharmacy, University of California, San Francisco, 3333 California Street, Suite 420, Box 0613, San Francisco, CA 94143, USA
Am J Public Health 95:S20-7. 2005..The tobacco industry played a role in establishing laws that increase corporate influence on public health and regulatory policy decisions...
- The birth of the e-clinic. Continuity or transformation in the UK governance of pharmaceutical consumption?Nick Fox
ScHARR, University of Sheffield, Regent Court, 30 Regent Street, Sheffield S1 4DA, UK
Soc Sci Med 61:1474-84. 2005..This continuity can be explained by Rosenau's (Along the Domestic-Foreign Frontier. Cambridge University Press, Cambridge, 1997) model of a contested and fragmenting process of technology governance...
- Perspectives on human stem cell researchKyu Won Jung
Law School, Hanyang University, 17 Haengdang dong, Seongdong Gu, Seoul 133 791, South Korea
J Cell Physiol 220:535-7. 2009..We do not need to exclude any type of stem cell research because each has its own merits and issues, and they can facilitate the scientific revolution when working together...
- European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287David J Flavell
Lancet 362:1415. 2003
- Unregulated private markets for health care in Canada? Rules of professional misconduct, physician kickbacks and physician self-referralSujit Choudhry
Faculty of Law, University of Toronto, ON
CMAJ 170:1115-8. 2004
- Declining sex ratio: role of society, technology and government regulation in Faridabad district, HaryanaA Bardia
Centre for Community Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
Natl Med J India 17:207-11. 2004..and acceptability of the practice of sex determination), technology (availability and affordability) and government regulation in the adverse ratio for girls in the Ballabgarh block of Haryana in northern India...
- A regulatory patchwork--human ES cell research oversightLori P Knowles
Health Law Institute, University of Alberta, Canada
Nat Biotechnol 22:157-63. 2004
- Rights, patents, markets and the global AIDS pandemicJames Thuo Gathii
Albany Law School, USA
Fla J Int Law 14:261-352. 2002
- The case for preemption of prescription drug failure-to-warn claimsChristine H Kim
Food Drug Law J 62:399-422. 2007
- A history of drug advertising: the evolving roles of consumers and consumer protectionJulie Donohue
University of Pittsburgh, Graduate School of Public Health, Department of Health Policy and Management, 130 DeSoto Street, Crabtree Hall A613, Pittsburgh, PA 15261, USA
Milbank Q 84:659-99. 2006....
- Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debateHoward L Dorfman
Bayer HealthCare LLC, West Haven, CT, USA
Food Drug Law J 61:585-622. 2006
- A cognitive scientist looks at DaubertGeorge P Lakoff
1203 Dwinelle Hall, University of California at Berkeley, Berkeley, CA 94720 2650, USA
Am J Public Health 95:S114-20. 2005..Daubert functions in its application as a strategic initiative that significantly moves America in a conservative direction, in the moral and political spheres, as well as in the legal sphere...
- Diversionary reframing of the Great Lakes Water Quality AgreementMichael Gilbertson
Occupational and Environmental Health Research Group, Stirling University, Scotland, UK
J Public Health Policy 28:201-15. 2007..The scientific evidence of continuing injury to health and property from trans-boundary pollution convinces us that this reframing is an unwarranted diversion from the original intent...
- Why Ashcroft is wrong on assisted suicideNelson Lund
George Mason University School of Law, USA
Commentary 113:50-5. 2002
- The creation of industry front groups: the tobacco industry and "get government off our back"Dorie E Apollonio
Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA 94143, USA
Am J Public Health 97:419-27. 2007..Those who seek to establish measures to protect public health should be prepared to counter the argument that government should not regulate private behavior...
- Philip Morris' FDA gambit: good for public health?Michael Givel
Department of Political Science, The University of Oklahoma, 455 West Lindsey, Room 2I7, Norman, USA
J Public Health Policy 26:450-68. 2005..On the other hand, tobacco products would have remained a politically and economically viable and legal product consumed by millions of Americans many of whom would have continued to suffer from tobacco-related illnesses and deaths...
- Death at a discount: how the tobacco industry thwarted tobacco control policies in US military commissariesElizabeth A Smith
Department of Social and Behavioral Sciences, University of California, San Francisco, Box 0612 San Francisco, CA 94143 0612, USA
Tob Control 16:38-46. 2007..Tobacco use also impairs short-term troop readiness...
- Drug risks and free speech--can Congress ban consumer drug ads?Miriam Shuchman
N Engl J Med 356:2236-9. 2007
- Politics, culture, and the lab: public attitudes toward animals and human embryonic stem cells have fostered different research agendas in Britain and the United StatesAnne Marie Borrego
Chron High Educ 51:A43-5. 2005
- The President's Council on Bioethics: my take on some of its deliberationsWilliam F May
Institute for Practical Bioethics and Public Life, University of Virginia, USA
Perspect Biol Med 48:229-40. 2005
- The impact of the cox-2 inhibitor issue on perceptions of the pharmaceutical industry: content analysis and communication implicationsRagnar E Lofstedt
King s Centre for Risk Management, King s College London, London, England
J Health Commun 12:471-91. 2007....
- Law's knowledge: science for justice in legal settingsSheila Jasanoff
John F Kennedy School of Government, School of Public Health, Department of the History of Science, Harvard University, 79 JFK Street, Room L354, Boston, MA, USA
Am J Public Health 95:S49-58. 2005..The important question for the law is not how judges can best do justice to science, but rather how courts can better render justice under conditions of uncertainty and ignorance...
- What has a decade of Daubert wrought?Margaret A Berger
Brooklyn Law School, 250 Joralemon Street, Room 911, Brooklyn, NY 11201, USA
Am J Public Health 95:S59-65. 2005..expert witnesses? What do we know about Daubert's impact on improving science in the court room? What has been Daubert's effect on access to the courts? Does Daubert further public policy objectives of protecting the public against harm?..
- Ten years of judicial gatekeeping under DaubertJoe S Cecil
Federal Judicial Center s Program on Scientific and Technical Evidence, One Columbus Circle, NE, Washington, DC 20002, USA
Am J Public Health 95:S74-80. 2005..Future research should focus on the pretrial screening of expert testimony and interactions between the attorneys and experts in shaping that testimony...
- From Asilomar to industrial biotechnology: risks, reductionism and regulationSheldon Krimsky
Department of Urban and Environmental Policy and Planning, Tufts University, Medford, MA 02155, USA
Sci Cult (Lond) 14:309-23. 2005
- Neoliberal and public health effects of failing to adopt OSHA's national secondhand tobacco smoke ruleMichael Givel
Department of Political Science, The University of Oklahoma, Norman 73109, USA
Int J Health Serv 36:137-55. 2006....
- The pharmaceutical industry's responsibility for protecting human subjects of clinical trials in developing nationsFinnuala Kelleher
Columbia Journal of Law and Social Problems, Columbia University, USA
Columbia J Law Soc Probl 38:67-106. 2004....
- Ethics and policy perspectives on personalized medicine in the post-genomic eraMelissa R Landon
Boston University, USA
J Biolaw Bus 8:28-36. 2005....
- Obesity--the new frontier of public health lawMichelle M Mello
Department of Health Policy and Management, Harvard School of Public Health, Boston, USA
N Engl J Med 354:2601-10. 2006
- Legal developments relevant to FDA authorityDaniel Meron
Department of Health and Human Services, USA
Food Drug Law J 62:441-4. 2007
- Daubert's menaceGio Batta Gori
Am J Public Health 96:206; discussion 206-7. 2006
- Public health. A case study of personalized medicineS H Katsanis
Genetics and Public Policy Center, Berman Institute of Bioethics [corrected, The Johns Hopkins University, Washington, DC 20036, USA
Science 320:53-4. 2008
- Privacy and policy for genetic researchJudith Wagner DeCew
Department of Philosophy, Clark University, 950 Main Street, Worcester, MA 01610, USA
Ethics Inf Technol 6:5-14. 2004....
- New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formationSusan Chimonas
Center on Medicine as a Profession (CMAP, College of Physicians and Surgeons, Columbia University, New York, NY, USA
Health Aff (Millwood) 24:949-60. 2005..We also explore the implications--some intended, others unanticipated--of the final document...
- Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefitDavid Wendler
Department of Clinical Bioethics, NIH Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA
JAMA 294:826-32. 2005..These data also raise the question of whether the federal minimal risk standard may sometimes fail to provide sufficient protection for children, prompting the need to consider alternative standards...
- The perils of relying on interested parties to evaluate scientific qualityWendy Wagner
University of Texas School of Law, 727 East Dean Keeton Street, Austin, TX 78705 3299, USA
Am J Public Health 95:S99-106. 2005....
- Pharmaceutical marketing practices: balancing public health and law enforcement interests; moving beyond regulation-through-litigationChristopher D Zalesky
World Wide Health Care Compliance, Johnson and Johnson, USA
J Health Law 39:235-64. 2006..This approach borrows lessons learned from the FDA's efficient and effective regulatory and enforcement methods and maintains a careful balance between the interests of patient-beneficiaries, the government and industry...
- A postmodernist take on the human embryo research debateLars Noah
University of Florida, USA
Conn Law Rev 36:1133-61. 2004
- Ethics, regulation, and biomedical researchMatthew Weed
Yale University, USA
Kennedy Inst Ethics J 14:361-8. 2004....
- Protecting research subjects--the crisis at Johns HopkinsRobert Steinbrook
N Engl J Med 346:716-20. 2002
- Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugsLars Noah
University of Florida, P O Box 117625, Gainesville, FL 32611 7625, USA
S C Law Rev 54:371-403. 2002..Otherwise, patients may continue to lose access to important therapeutic products...
- Human research protections: time for regulatory reform?Karen J Maschke
Hastings Cent Rep 38:19-22. 2008
- Children in clinical research: a conflict of moral valuesVera Hassner Sharav
The Alliance for Human Research Protection
Am J Bioeth 3:W-IF 2. 2003....
- A comprehensive national policy to stop human cloning: an analysis of the Human Cloning Prohibition Act of 2001 with recommendations for federal and state legislaturesShawn E Peterson
Notre Dame Law School, USA
Notre Dame J Law Ethics Public Policy 17:217-68. 2003
- Experts warn drug industry, government about weaknesses in drug supply chainDonna Young
Am J Health Syst Pharm 60:2176, 2180, 2184. 2003
- Private wealth and public health: a critique of Richard Epstein's defense of the "old" public healthWilliam J Novak
Department of History, University of Chicago, 1126 East 59th Street, Chicago, IL 60637, USA
Perspect Biol Med 46:S176-98. 2003....
- Cloning and stem cells--handicapping the political and scientific debatesGeorge Q Daley
Whitehead Institute for Biomedical Research, Cambridge, USA
N Engl J Med 349:211-2. 2003
- The need for FDA regulation of tobacco productsEdward M Kennedy
Yale J Health Policy Law Ethics 3:101-8. 2002
- Clinical trials face heightened scrutiny as science and commerce appear to mergeAlvin J Lorman
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, USA
J Biolaw Bus 4:23-32. 2001..The risk of increased government involvement includes criminal prosecution of physicians for failing to follow the rules, as an innovative case in California demonstrates...
- Molecular diagnostics: an FDA perspectiveAli M Ardekani
Department of Therapeutic Proteins, CBER, FDA, Bethesda, MD 20892, USA
Expert Rev Mol Diagn 3:129-40. 2003....
- Informed consent and investigational new drug abuses in the U.S. militaryMary L Cummings
Systems Engineering, University of Virginia, PO Box 400747, Charlottesville, VA 22904 4747, USA
Account Res 9:93-103. 2002....
- America's other drug problem: how the drug industry distorts medicine and politicsArnold S Relman
Harvard Medical School, USA
New Repub 227:27-41. 2002
- The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'ReillyDavid C Vladeck
Georgetown University Law Center Center of Health Regulation and Governance of the O Neill Institute for National and Global Health Law Institute for Public Representation and Center for Progressive Reform, USA
Cornell Law Rev 93:981-1002. 2008
- Pharmacogenetics: ethical issues and policy optionsAllen Buchanan
Department of Philosophy, University of Arizona, Tucson, AZ, USA
Kennedy Inst Ethics J 12:1-15. 2002..We analyze each of these categories of ethical issues and provide policy approaches for addressing them...
- Liability for institutional review boards: from regulation to litigationDavid B Resnik
The Brody School of Medicine at East Carolina University, Greenville, North Carolina, USA
J Leg Med 25:131-84. 2004
- Taking another look at the definition of an embryo: President Bush's criteria and the problematic application of federal regulations to human embryonic stem cellsSimon B Auerbach
Emory University School of Law, Atlanta, Georgia, USA
Emory Law J 51:1557-604. 2002
- Dipping into Uncle Sam's pockets: federal funding of stem cell research: is it legal?Carly Goldstein
Boston Univ Public Interest Law J 11:229-59. 2002
- The federal preemption debate in pharmaceutical labeling product liability actionsJodie M Gross
Harris Beach PLLC, New York, New York, USA
Tort Trial Insur Pract Law J 43:35-70. 2007
- Balancing government regulation against access to drugs: address to Seton Hall University School of Law, February 16, 2007Daniel Meron
United States Department of Health and Human Services, USA
Seton Hall Law Rev 37:929-39. 2007
- FDA and EMEA pool scientific adviceAlla Katsnelson
Nat Biotechnol 22:1490-1. 2004
- Bioethical malpractice: risk and responsibilities in human researchBarbara A Noah
Health Law and Policy, University of Florida Levin College of Law, P.O. Box 117629, Gainesville, FL 32611-7629, USA
J Health Care Law Policy 7:175-241. 2004
- Reflections of a forensic psychiatrist in Washington: politics and policyRenee L Binder
Psychiatry and the Law Program, University of California, San Francisco, CA, USA
J Am Acad Psychiatry Law 32:324-8. 2004
- Liberalism, communitarianism, and public health: comments on Lawrence O. Gostin's lectureWendy E Parmet
Northeastern University, USA
Fla Law Rev 55:1221-40. 2003
- Puppy love: bioterrorism, civil rights, and public healthGeorge J Annas
Health Law Department, Boston University School of Public Health, USA
Fla Law Rev 55:1171-90. 2003
- When terrorism threatens health: how far are limitations on personal and economic liberties justified?Lawrence O Gostin
Georgetown Univesity, Washington, DC, USA
Fla Law Rev 55:1105-70. 2003
- Nontherapeutic research with children: the virtues and vices of legal uncertaintyDavid M Smolin
Cumberland Law School, Samford University, USA
Cumberland Law Rev 33:621-45. 2002
- Bush tails follow-onsJeff Fox
Nat Biotechnol 26:366. 2008
- Senators grill NIH director over restrictions on stem-cell researchJeffrey Brainard
Chron High Educ 49:A25. 2003
- The first pharmacoepidemiologic investigations: national drug safety policy in the United States, 1901-1902David E Lilienfeld
Perspect Biol Med 51:188-98. 2008..That power, welcomed by manufacturers to restore the public's trust in their products, was enhanced in the 1906 Food and Drug Act, which created the Food and Drug Administration...
- Safety in New Zealand's adventure tourism industry: the client accident experience of adventure tourism operatorsT A Bentley
Centre for Tourism Research, Department of Management and International Business, Massey University, Albany, New Zealand
J Travel Med 7:239-45. 2000..CONCLUSIONS: The prevalence of client injuries in activity sectors not presently covered by government regulation, suggests policy makers should look again at extending codes of practice to a wider range of adventure ..
- Is there a need for professional regulation for primary care mental health workers?Soo Lee
School of Social Community and Health Studies, University of Hertfordshire, Hatfield, Herts, UK
Qual Prim Care 16:263-7. 2008..This paper argues that professional regulation is not needed as there are other systems with similar significance that promote quality of care and can offer protection to the public...
- [Tuberculosis vaccination programs: where are we?]C Manaouil
Consultation de médecine légale, CHU d Amiens, Place Victor Pauchet, 80054 Amiens Cedex 1, France
Arch Pediatr 15:1100-6. 2008..In parallel, a national programme of fight against tuberculosis 2007-2009 is launched...
- MotherNature: establishing a Canadian research network for natural health products (NHPs) during pregnancy and lactationGideon Koren
Motherisk Program, Hospital for Sick Children, Toronto, Ontario, Canada
J Altern Complement Med 14:369-72. 2008....
- Alberta to limit self-regulationDeborah Jones
CMAJ 177:1342. 2007
- Is the metaphor of 'barriers to change' useful in understanding implementation? Evidence from general medical practiceKath Checkland
National Primary Care Research and Development Centre, University of Manchester, Manchester, UK
J Health Serv Res Policy 12:95-100. 2007....
- Medicare bad debts-take twoJoanne B Erde
Duane Morris, LLP, Miami, USA
Healthc Financ Manage 62:24-5, 27. 2008
- Legal aspects of tissue bankingUlrich M Gassner
Faculty of Law, University of Augsburg, Augsburg, Germany
Pathobiology 74:270-4. 2007..Consequently, anybody involved in tissue banking is well advised to observe the evolution of the legal and regulatory environment in the particular jurisdiction...
- Synthetic genomics | options for governanceMichele S Garfinkel
J. Craig Venter Institute, Rockville, Maryland, USA
Biosecur Bioterror 5:359-62. 2007
- Orthopaedic joint devices: the FDA's short answers to your questionsJonette R Foy
Orthopaedic Joint Devices Branch, Division of General, Restorative and Neurological Devices, Center for Devices and Radiological Health, US Food and Drug Administration, Rockville, MD, USA
J Am Acad Orthop Surg 16:S123-8. 2008..The FDA relies on accurate scientific evidence and regulatory science to determine the safety and effectiveness of orthopaedic joint devices...
- Re: Commercialism, choice and consumer protection: regulation of complementary medicines in AustraliaNigel A Pollard
Med J Aust 189:50-2; author reply 52-3. 2008
- Bureaucratic obstruction of conservation science in the Guayana HighlandsValentí Rull
Conserv Biol 22:508-9. 2008
- "The mercury's rising!" Can national health group intervention protect the public health from EPA'S Clean Air Mercury Rule?James D Stivers
Southern Illinois University School of Law, IL 62901, USA
J Leg Med 27:323-40. 2006
- Practical and effective ALARAJoseph John Bevelacqua
Bevelacqua Resources, 343 Adair Drive, Richland, WA 99352, USA
Health Phys 98:S39-47. 2010....
- Mandatory reporting of diseases and conditions by health care professionals and laboratoriesS Roush
Council of State and Territorial Epidemiologists, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
JAMA 282:164-70. 1999..Systematic reporting by health care professionals and laboratories, which may vary by state law, statute, or regulation, continues to provide essential data for assessing public health...
- A European perspective on animal cloning and government regulationCesare Galli
Laboratorio di Tecnologie della Riproduzione, Consorzio per l'Incremento Zootecnico, Associazione Italiana Allevatori, Cremona, Italy
IEEE Eng Med Biol Mag 23:52-4. 2004
- Where have all the young girls gone? Preconception gender selection in India and the United StatesKenan Farrell
Indiana University School of Law Indianapolis, USA
Indiana Int Comp Law Rev 13:253-81. 2002
- New waiver of regulations on research with prisoner-subjectsDennis M Maloney
The Deem Corporation, P.O. Box 44069, Omaha, NE 68144, USA
Hum Res Rep 18:1-2. 2003
- Human gene therapy and slippery slope argumentsT McGleenan
School of Law, Queen s University of Belfast
J Med Ethics 21:350-5. 1995....
Research Grants161 found, 100 shown here
- Trends and Trajectories of Oral Health Among Older Americans: The Role of CognitBei Wu; Fiscal Year: 2009..S. makes geriatric oral health an increasingly important public health issue that this study will address. This study will lead to the development of effective prevention and intervention strategies. ..
- Proxy Decision Making for Alzheimer Disease ResearchLaura Dunn; Fiscal Year: 2009....
- Biology of Fungal MelaninArturo Casadevall; Fiscal Year: 2009..In this regard, a monoclonal antibody to fungal melanin made as part of this research program is already in clinical evaluation for the therapy of melanoma. ..
- Youth Alcohol, Tobacco and Marijuana Use: Effects of Hours of Work and WagesRobert Kaestner; Fiscal Year: 2009..The proposed research will identify the importance of employment and earned income on youth substance use and produce information that can be used to design effective public health policy to address this problem. ..
- Synergy of Host Defense Mechanisms in the LungArturo Casadevall; Fiscal Year: 2009..Furthermore, these studies will provide information that could be used to design vaccines and new therapies based on immunological reagents such as antibodies. ..
- Impact of Medicare Part D on Racial Disparities in Diabetes Treatment and OutcomeJulie Marie Donohue; Fiscal Year: 2010....
- Impact of Poor Health & AIDS on Small Businesses in SAMark Pauly; Fiscal Year: 2003..They will be useful for predicting the effect of changes in health on economic activity in this sector, and for allocating resources for disease prevention and treatment. ..
- National Black Leadership Conference on GeneticsKathy Hudson; Fiscal Year: 2004..The Conference will be held in Washington DC in May 2004. ..
- Making Every Voice Count: Public Consultation on Genetics, Environment and HealthKathy Hudson; Fiscal Year: 2007..abstract_text> ..
- Making Every Voice Count: Public Consultation on Genetics, Environment and HealthJoan Scott; Fiscal Year: 2007....
- NEWBORN GENETIC SCREENING:FOR WHOSE BENEFIT?Lainie Ross; Fiscal Year: 2005..OUTCOMES: The major outcomes will be a series of peer-reviewed articles and a full-length book entitled Newborn Genetic Screening: In whose Interest? For whose Benefit? ..
- The Effect of Aflatoxin Regulation on Global Liver Cancer RiskFelicia Wu; Fiscal Year: 2010..While we focus on the impact of a harmonized aflatoxin standard on global liver cancer burden, the methodologies can be broadened to address standard-setting of other important carcinogens. ..
- SYNERGY OF HOST DEFENSE MECHANISMS IN LUNGArturo Casadevall; Fiscal Year: 2006..By comparing the immune response in Ab-permissive and Ab-non-permissive murine strains we will learn the conditions and mechanisms by which Ab-mediates protection against C. neoformans. ..
- ERYTHROCYTAPHERESIS TO LOWER IRON LOADING IN THALASSEMIAAlan Cohen; Fiscal Year: 2002....
- Effects of Dioxin on Vietnamese CiviliansDavid Carpenter; Fiscal Year: 2004..7. ..
- Providers' perceptions of the diaphragm in Southern Afr*Cynthia Harper; Fiscal Year: 2005..As the diaphragm effectiveness results become available, data from this proposed study will position us to design counseling interventions and to address provider education and training needs. ..
- NATIONAL RESEARCH SERVICE AWARDVincent Mor; Fiscal Year: 2007....
- Environmental Epidemiology in Community SettingsDavid Ozonoff; Fiscal Year: 2007..It also includes activities to enrich the experience of the trainees and promote social and professional cohesion. ..
- State Policies and Hospitalizations from Nursing HomesVincent Mor; Fiscal Year: 2004..These theoretical insights will help shape the policy implications emerging from the study. ..
- LONGITUDINAL ORAL HEALTH OUTCOMES IN HIGH-RISK ADULTSGREGG GILBERT; Fiscal Year: 2003....
- Stem-Cell Based Tissue Engineering in Regenerative Medicine ConferenceJeremy Mao; Fiscal Year: 2006..abstract_text> ..
- Interventions for Tobacco Dependent AdolescentsDorothy Hatsukami; Fiscal Year: 2005....
- Suicidality in Schizophrenia: Risk & Protective FactorsDEQUINCY LEZINE; Fiscal Year: 2004..abstract_text> ..
- ARE FEDERAL REGULATIONS ON ALCOHOL USE SAFEJonathan Howland; Fiscal Year: 2001..The results of this study will provide information on the risks of hangovers for injury and may inform public policy on alcohol use in conjunction with commercial ship operation. ..
- Tracking stem cells in engineered tissue and organs in vivo and in real timeJeremy J Mao; Fiscal Year: 2010..It also has a potential to contribute to our understanding of the engineered osteochondral interface that is of critical value in bioengineered replacement of arthritic joints. ..
- OUTCOMES OF HOSPITAL STAFFINGLinda Aiken; Fiscal Year: 1999....
- SAFEHAVEN: Decision Support for Nursing Home Resident Disaster EvacuationsVincent Mor; Fiscal Year: 2010..Using existing nursing home data from multiple sources, this study seeks to understand the consequences of hurricanes and evacuation decisions, providing the first evidence base to inform the creation of evacuation guidelines. ..
- FREE PLASMA SEX HORMONE AND ANDROGEN ACTIONRobert Rosenfield; Fiscal Year: 1980..The hypothesis that LH is insensitive to modest decrements of plasma testosterone will be tested by acutely lowering plasma testosterone levels in normal volunteers with aminoglutethimide...
- Community VOICES (2):Community VOICES on informed consent in emergency situationsLynne D Richardson; Fiscal Year: 2010..The entire toolkit will be made publicly available on the Mount Sinai EM website and will be actively disseminated to medical societies, governmental agencies, bioethics organizations &others. ..
- SITE-SPECIFIC MUTAGENESIS OF ISOMERASESGregory Petsko; Fiscal Year: 1990..Finally, mutations will be made at several other positions where the crystallographic results and sequence conservation imply a possible role in either active site architecture or catalysis: Ser 96, Cys 126, Glu 97, and Asn 10...
- Stem Cell Based Soft Tissue ReconstructionJeremy Mao; Fiscal Year: 2009..An interdisciplinary team of biomedical engineers, biologists, biomaterial scientists, imaging scientists and surgical consultants have been assembled to meet the challenges of realizing our goals. ..
- Engineering of Vascularized BoneJeremy J Mao; Fiscal Year: 2010....
- Annotating functional sites in 3D biological structuresRUSS BIAGIO ALTMAN; Fiscal Year: 2010..In particular, we will focus our new capabilities on three difficult function annotation challenges: ATP binding sites, phosphorylation sites, and metabolizing enzyme active sites. ..
- Community VOICES (2):Community VOICES on informed consent in emergency situationsLynne Richardson; Fiscal Year: 2009..The entire toolkit will be made publicly available on the Mount Sinai EM website and will be actively disseminated to medical societies, governmental agencies, bioethics organizations & others. ..
- PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONSArturo Casadevall; Fiscal Year: 2007..neoformans and also to other efforts to develop Ab therapy, vaccines and fundamental immunology. ..
- Dental PBRN Network ChairGREGG GILBERT; Fiscal Year: 2006..To our knowledge, we have more experience with dental practice-based research than any other team in the nation, which will enhance our anticipated success with the Dental PBRN. ..
- Biology of Fungal MelaninArturo Casadevall; Fiscal Year: 2007..It is anticipated that the work proposed here will provide important insights into the biology of melanin and in doing so highlight novel strategies for antimicrobial drug development. ..
- Mid-Career Investigator Award-Patient-Oriented ResearchGREGG GILBERT; Fiscal Year: 2005....
- Impact of Changing Medicaid Policies on NH QualityVincent Mor; Fiscal Year: 2006..abstract_text> ..
- DEMOLITION AND ASTHMA IN CHICAGO PUBLIC HOUSINGSamuel Dorevitch; Fiscal Year: 2006....
- HOW NURSING AFFECTS THE VOLUME-OUTCOMES RELATIONSHIPLinda Aiken; Fiscal Year: 2003....
- Welfare Reform, Fertility and Reproductive BehaviorRobert Kaestner; Fiscal Year: 2003....
- UAB Oral Health Research Infrastructure ImprovementGREGG GILBERT; Fiscal Year: 2003..abstract_text> ..
- Hospice Enrollment and LTC Policy (HELP)Susan Miller; Fiscal Year: 2007....
- SAFEHAVEN: Decision Support for Nursing Home Resident Disaster EvacuationsVincent Mor; Fiscal Year: 2010..Using existing nursing home data from multiple sources, this study seeks to understand the consequences of hurricanes and evacuation decisions, providing the first evidence base to inform the creation of evacuation guidelines. ..
- LONGITUDINAL ORAL HEALTH OUTCOMES IN HIGH-RISK ADULTSGREGG GILBERT; Fiscal Year: 2002....
- A Comparative Study of International Law and Public Health PreparednessRebecca Katz; Fiscal Year: 2007..The project also addresses several sub-goals, including 'examining the impact of international health regulations on public health infrastructure,' and 'law as a cross cutting research tool. ..
- Xylitol Adult Caries Trial (X-ACT): UAB Clinical CenterGREGG GILBERT; Fiscal Year: 2007..Little research has been done on methods to prevent tooth decay in adults. This study would test how well a lozenge to be taken several times a day works to prevent tooth decay in adults who are prone to tooth decay. ..
- DO GOOD NURSING HOMES ACHIEVE GOOD OUTCOMES?Vincent Mor; Fiscal Year: 2003..This latter exploratory data analysis step is crucial to derive from the theoretical results insights about how to intervene in a nursing home to improve the chance of achieving positive outcomes. ..